[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1197 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1197
To reauthorize the Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 11, 2025
Ms. Kelly of Illinois (for herself, Mrs. Miller-Meeks, Mrs. Fletcher,
Mr. Carter of Georgia, Ms. Brown, and Mrs. Kiggans of Virginia)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To reauthorize the Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``PREEMIE Reauthorization Act of
2025''.
SEC. 2. PREEMIE.
(a) Research Relating to Preterm Labor and Delivery and the Care,
Treatment, and Outcomes of Preterm and Low Birthweight Infants.--
(1) In general.--Section 3(e) of the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early
Act (42 U.S.C. 247b-4f(e)) is amended by striking ``fiscal
years 2019 through 2023'' and inserting ``fiscal years 2025
through 2029''.
(2) Technical correction.--Effective as if included in the
enactment of the PREEMIE Reauthorization Act of 2018 (Public
Law 115-328), section 2 of such Act is amended, in the matter
preceding paragraph (1), by striking ``Section 2'' and
inserting ``Section 3''.
(b) Interagency Working Group.--Section 5(a) of the PREEMIE
Reauthorization Act of 2018 (Public Law 115-328) is amended by striking
``The Secretary of Health and Human Services, in collaboration with
other departments, as appropriate, may establish'' and inserting ``Not
later than 18 months after the date of the enactment of the PREEMIE
Reauthorization Act of 2025, the Secretary of Health and Human
Services, in collaboration with other departments, as appropriate,
shall establish''.
(c) Study on Preterm Births.--
(1) In general.--The Secretary of Health and Human Services
shall enter into appropriate arrangements with the National
Academies of Sciences, Engineering, and Medicine under which
the National Academies shall--
(A) not later than 30 days after the date of
enactment of this Act, convene a committee of experts
in maternal health to study premature births in the
United States; and
(B) upon completion of the study under subparagraph
(A)--
(i) approve by consensus a report on the
results of such study;
(ii) include in such report--
(I) an assessment of each of the
topics listed in paragraph (2);
(II) the analysis required by
paragraph (3); and
(III) the raw data used to develop
such report; and
(iii) not later than 24 months after the
date of enactment of this Act, transmit such
report to--
(I) the Secretary of Health and
Human Services;
(II) the Committee on Energy and
Commerce of the House of
Representatives; and
(III) the Committee on Finance and
the Committee on Health, Education,
Labor, and Pensions of the Senate.
(2) Assessment topics.--The topics listed in this
subsection are each of the following:
(A) The financial costs of premature birth to
society, including--
(i) an analysis of stays in neonatal
intensive care units and the cost of such
stays;
(ii) long-term costs of stays in such units
to society and the family involved post-
discharge; and
(iii) health care costs for families post-
discharge from such units (such as medications,
therapeutic services, co-payments for visits,
and specialty equipment).
(B) The factors that impact preterm birth rates.
(C) Opportunities for earlier detection of
premature birth risk factors, including--
(i) opportunities to improve maternal and
infant health; and
(ii) opportunities for public health
programs to provide support and resources for
parents in-hospital, in non-hospital settings,
and post-discharge.
(3) Analysis.--The analysis required by this subsection is
an analysis of--
(A) targeted research strategies to develop
effective drugs, treatments, or interventions to bring
at-risk pregnancies to term;
(B) State and other programs' best practices with
respect to reducing premature birth rates; and
(C) precision medicine and preventative care
approaches starting early in the life course (including
during pregnancy) with a focus on behavioral and
biological influences on premature birth, child health,
and the trajectory of such approaches into adulthood.
<all>